Back to Sites

Seke North CRS

Site Number

30306

Address

Seke North CRS
15 Phillips Avenue
Belgravia
Harare,
Zimbabwe

IMPAACT Members at this Site

Lynda Stranix-Chibanda Clinical/Site Coordinator

Suzen Maonera CRS Coordinator

Teacler Nematadzira CRS Coordinator

Zvavahera Chirenje CTU Principal Investigator

Bola Adedeji DAIDS PO

Daylight Sanyanga Ngwazi Investigator

Marshall Munjoma Laboratory Manager/Supervisor

Bangani Kusakara Medical Officer

Vongai Chanaiwa Pharmacist

Caroline Govathson Pharmacist of Record

Studies at this Site

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

10732

Research Area

Tuberculosis

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Complications & Comorbidities

Study Status

Closed to Follow Up

1077BF: PROMISE 1077BF

DAIDS Number

10777

Research Area

Prevention

Study Status

Participants Off Study and Primary Analysis Completed

P1115: Very Early Intensive Tx on HIV-Infected Infants

DAIDS Number

11954

Research Area

Cure

Study Status

Enrolling

IMPAACT 2009 : Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants

DAIDS Number

30020

Research Area

Prevention

Study Status

Enrolling

IMPAACT 2010: VESTED

DAIDS Number

30129

Research Area

Treatment

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2016: Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence Among Youth Living with HIV in Low Resource Settings

DAIDS Number

38506

Research Area

Complications & Comorbidities

Study Status

Open to Accrual

IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

DAIDS Number

38609

Research Area

Treatment

Study Status

Enrolling

IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

DAIDS Number

38693

Research Area

Cure

Study Status

Open to Accrual